TCM Etiological Study on the Theory of XuSunShengJi in Liver Cirrhosis

NCT00540397 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2007-10-08

No results posted yet for this study

Summary

To Elucidate and Confirm the Theory of XuSunShengJi in the Traditional Chinese Medicine Etiological Pathogenesis of Liver Cirrhosis.

Conditions

Interventions

DRUG

Fuzhenghuayu Tablet, Huangqi Decoction Granule

Sponsors & Collaborators

  • Shanghai University of Traditional Chinese Medicine

    lead OTHER

Principal Investigators

  • Ping Liu, Professor · Shanghai University of Traditional Chinese Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Countries

  • China

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00540397 on ClinicalTrials.gov